CBDS Relative Valuation - Cannabis Sativa Inc

Watchlist Manager

Watchlist

Price: 0.033 USD 0.61% Market Closed

Market Cap: $2.9m

	Cannabis Sativa Inc OTC:CBDS	US
	Vista Energy SAB de CV F:1CIA	MX
	DG Innovate PLC LSE:DGI	UK

Multiples-Based Value

CBDS doesn't have a meaningful market cap.

The Multiples-Based Value of one CBDS stock under the Base Case scenario is 0.024 USD. Compared to the current market price of 0.033 USD, Cannabis Sativa Inc is Overvalued by 28%.

Multiples-Based Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.

What is Relative Valuation?

How is Multiples-Based Value calculated?

CBDS Multiples-Based Value

Base Case

Overvaluation 28%

Multiples-Based Value

Price $0.033

Worst Case

Base Case

Best Case

Valuation Multiples

View Details

Multiples Across Competitors

All Multiples

P/S

P/E

EV/EBITDA

EV/EBIT

Forward Multiples

			Market Cap	P/S	P/E	EV/EBITDA	EV/EBIT
US		Cannabis Sativa Inc OTC:CBDS	2.9m USD	3.3	-2.6	-4.3	-4.1
US		CVS Health Corp NYSE:CVS	92.1B USD	0.2	52.1	13.5	13.5
US	C	Cigna Group XMUN:CGN	67.2B EUR	0.3	13.1	7.7	9.8
US		Cigna Corp NYSE:CI	70.4B USD	0.3	11.8	0	0
DE		Fresenius SE & Co KGaA XETRA:FRE	24.8B EUR	1.1	19.6	9.3	13.9
DE		Fresenius Medical Care AG XMUN:FME	22.9B EUR	1.2	23.4	9	16.7
US		Laboratory Corporation of America Holdings NYSE:LH	22.4B USD	1.6	25.6	12.2	17.7
US		Quest Diagnostics Inc NYSE:DGX	21.7B USD	2	22	11.9	16
DE	F	Fresenius Medical Care AG & Co KGaA XETRA:FME	10.8B EUR	0.5	11	5.3	9.8
US		Guardant Health Inc NASDAQ:GH	11.9B USD	12.1	-28.6	-31.3	-28.4
US		DaVita Inc NYSE:DVA	10.3B USD	0.8	13.8	7.2	9.7

				Revenue Growth	P/S to Growth
US		Cannabis Sativa Inc OTC:CBDS	Average P/S: 2.1 3.3	N/A	N/A
US		CVS Health Corp NYSE:CVS	0.2	4%	0.1
US	C	Cigna Group XMUN:CGN	0.3	6%	0
US		Cigna Corp NYSE:CI	0.3	6%	0
DE		Fresenius SE & Co KGaA XETRA:FRE	1.1	5%	0.2
DE		Fresenius Medical Care AG XMUN:FME	1.2	3%	0.4
US		Laboratory Corporation of America Holdings NYSE:LH	1.6	6%	0.3
US		Quest Diagnostics Inc NYSE:DGX	2	5%	0.4
DE	F	Fresenius Medical Care AG & Co KGaA XETRA:FME	0.5	3%	0.2
US		Guardant Health Inc NASDAQ:GH	12.1	29%	0.4
US		DaVita Inc NYSE:DVA	0.8	4%	0.2

				Earnings Growth	PEG
US		Cannabis Sativa Inc OTC:CBDS	Average P/E: 21.4 Negative Multiple: -2.6	N/A	N/A
US		CVS Health Corp NYSE:CVS	52.1	90%	0.6
US	C	Cigna Group XMUN:CGN	13.1	19%	0.7
US		Cigna Corp NYSE:CI	11.8	19%	0.6
DE		Fresenius SE & Co KGaA XETRA:FRE	19.6	26%	0.8
DE		Fresenius Medical Care AG XMUN:FME	23.4	16%	1.5
US		Laboratory Corporation of America Holdings NYSE:LH	25.6	27%	0.9
US		Quest Diagnostics Inc NYSE:DGX	22	12%	1.8
DE	F	Fresenius Medical Care AG & Co KGaA XETRA:FME	11	16%	0.7
US		Guardant Health Inc NASDAQ:GH	Negative Multiple: -28.6	N/A	N/A
US		DaVita Inc NYSE:DVA	13.8	20%	0.7

				EBITDA Growth	EV/EBITDA to Growth
US		Cannabis Sativa Inc OTC:CBDS	Average EV/EBITDA: 9.5 Negative Multiple: -4.3	N/A	N/A
US		CVS Health Corp NYSE:CVS	13.5	28%	0.5
US	C	Cigna Group XMUN:CGN	7.7	4%	1.9
US		Cigna Corp NYSE:CI	Not Available	N/A	N/A
DE		Fresenius SE & Co KGaA XETRA:FRE	9.3	10%	0.9
DE		Fresenius Medical Care AG XMUN:FME	9	7%	1.3
US		Laboratory Corporation of America Holdings NYSE:LH	12.2	10%	1.2
US		Quest Diagnostics Inc NYSE:DGX	11.9	6%	2
DE	F	Fresenius Medical Care AG & Co KGaA XETRA:FME	5.3	7%	0.8
US		Guardant Health Inc NASDAQ:GH	Negative Multiple: -31.3	N/A	N/A
US		DaVita Inc NYSE:DVA	7.2	4%	1.8

				EBIT Growth	EV/EBIT to Growth
US		Cannabis Sativa Inc OTC:CBDS	Average EV/EBIT: 13.4 Negative Multiple: -4.1	N/A	N/A
US		CVS Health Corp NYSE:CVS	13.5	22%	0.6
US	C	Cigna Group XMUN:CGN	9.8	5%	2
US		Cigna Corp NYSE:CI	Not Available	N/A	N/A
DE		Fresenius SE & Co KGaA XETRA:FRE	13.9	12%	1.2
DE		Fresenius Medical Care AG XMUN:FME	16.7	11%	1.5
US		Laboratory Corporation of America Holdings NYSE:LH	17.7	18%	1
US		Quest Diagnostics Inc NYSE:DGX	16	9%	1.8
DE	F	Fresenius Medical Care AG & Co KGaA XETRA:FME	9.8	11%	0.9
US		Guardant Health Inc NASDAQ:GH	Negative Multiple: -28.4	N/A	N/A
US		DaVita Inc NYSE:DVA	9.7	5%	1.9

Cannabis Sativa Inc
OTC:CBDS

Multiples-Based Value

Valuation Multiples

Multiples Across Competitors

CBDS Competitors Multiples
Cannabis Sativa Inc Competitors

See Also

Company

Help

Tools

Stocks

Cannabis Sativa Inc OTC:CBDS

Multiples-Based Value

Valuation Multiples

Multiples Across Competitors

CBDS Competitors Multiples Cannabis Sativa Inc Competitors

See Also

Company

Help

Tools

Stocks

Cannabis Sativa Inc
OTC:CBDS

CBDS Competitors Multiples
Cannabis Sativa Inc Competitors